Ross Labs
This article was originally published in The Tan Sheet
Executive Summary
Abbott Senior VP-Finance and Chief Financial Officer Gary Coughlan tells May 10 session at Alex. Brown investment conference that the company's nutrition R&D is "focusing on improved pediatric formulas, new disease-specific products" like the medical nutritional Advera, and "new packages and systems" for existing products. He noted that the company's medical nutritional sales increased 15% in 1993 to $850 mil., and that Abbott maintains its leadership position in hospitals, nursing homes and retail outlets